Early clinical data presented at the ECNP Congress show predictable psychedelic effects and measurable changes in brain activity, as the...
As psychedelic-assisted therapy develops, researchers are investigating how music, visual imagery and treatment environments influence patients' experiences, and whether these...
The Canadian pharmaceutical manufacturer says it is supplying 26 Australian clinics with naturally derived psilocybin and is targeting further growth...
Academic researchers, clinicians, healthcare entrepreneurs and investors feature in the first announcement for Melbourne’s psychedelic medicine symposium, with major keynote...
The Australian-founded biotechnology company is progressing three investigational treatments, including a synthetic psilocybin therapy for generalised anxiety disorder, as its...
© 2026 Psychedelics.media - A division of Dot Media Corp.
© 2026 Psychedelics.media - A division of Dot Media Corp.